Oncogene-mediated metabolic gene signature predicts breast cancer outcome
Merve Aslan, En‐Chi Hsu, Fernando Jose Garcia-Marques, Abel Bermudez, Shiqin Liu, Michelle Shen, Meredith West, Chiyuan Amy Zhang, Meghan A. Rice, James D. Brooks, Robert B. West, Sharon J. Pitteri, Balázs Győrffy, Tanya Ivanova Stoyanova
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1038/s41523-021-00341-6 ↗
- Volume · Issue · Pages
- 7 · 1 · 141-141
- Publisher
- Nature Publishing Group
- Article URL
- https://doi.org/10.1038/s41523-021-00341-6 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
28 Oct 2021
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 28 Oct 2021 | OpenAlex |
Keywords (as given): triple-negative breast cancer; TROP2; oncogenes; cancer metabolism; metabolic gene signature; prognostic factors; GPI; LDHA; SHMT2; ADK; gene expression profiling; patient survival prediction; tumor growth
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
W
Based on the recorded HEC dataset applicable to the article's publication date. Listed as W in the HEC list for hjrs 2021-22 V2.
- Journal
- npj Breast Cancer
- Publication date used
- 28 Oct 2021 (OpenAlex publication date)
- Applicable HEC period
- hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
- Category
- W
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- hjrs-2021-22 row 1708
- Verification status
- Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.
